DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
GIMATECAN
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Myelodysplastic Syndromes; Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma
Unknown
GIMATECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
7KKS9R192F
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O5
Molecular Weight:
447.49
AlogP:
3.23
PSA:
103.01
HBD:
1.0
HBA:
#RotB:
3.0
Source:
POSENACAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
POSENACAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
BN5UT8I0T9
Molecule Type:
Small molecule
Molecular Formula:
C27H27NO5
Molecular Weight:
445.52
AlogP:
6.16
PSA:
81.79
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RGI-7000
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis B, Chronic; Hepatitis C, Chronic; Lung Neoplasms; Multiple Myeloma
Unknown
RGI-7000
×
Maximum Phase:
1
First Approval:
None
UNII:
WX671898JF
Molecule Type:
Small molecule
Molecular Formula:
C50H99NO9
Molecular Weight:
858.34
AlogP:
10.48
PSA:
168.94
HBD:
7.0
HBA:
#RotB:
44.0
Source:
LXS-196
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LXS-196
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
LUFOTRELVIR
1
Small molecule
Investigational
Unknown
Unknown
Virus Diseases
Unknown
LUFOTRELVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C24H33N4O9P
Molecular Weight:
552.52
AlogP:
1.01
PSA:
196.15
HBD:
6.0
HBA:
#RotB:
13.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULCARDINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SULCARDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
4Q5HLV8HG1
Molecule Type:
Small molecule
Molecular Formula:
C24H33N3O4S
Molecular Weight:
459.61
AlogP:
3.07
PSA:
82.11
HBD:
2.0
HBA:
#RotB:
9.0
Source:
HE3235
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Androgen Receptor modulator
HE3235
×
Maximum Phase:
1
First Approval:
None
UNII:
891O182ZP5
Molecule Type:
Small molecule
Molecular Formula:
C21H32O2
Molecular Weight:
316.49
AlogP:
3.75
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
ALETHINE
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Multiple Myeloma
Unknown
ALETHINE
×
Maximum Phase:
1
First Approval:
None
UNII:
LY583605Y8
Molecule Type:
Small molecule
Molecular Formula:
C10H22N4O2S2
Molecular Weight:
294.45
AlogP:
-0.7
PSA:
110.24
HBD:
4.0
HBA:
#RotB:
11.0
Source:
TRICHOSTATIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TRICHOSTATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
3X2S926L3Z
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2O3
Molecular Weight:
302.37
AlogP:
2.58
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TALINOLOL
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Obesity, Morbid
Unknown
TALINOLOL
×
Maximum Phase:
1
First Approval:
None
UNII:
3S82268BKG
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O3
Molecular Weight:
363.5
AlogP:
3.27
PSA:
82.62
HBD:
4.0
HBA:
#RotB:
7.0
Source:
SERDEMETAN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SERDEMETAN
×
Maximum Phase:
1
First Approval:
None
UNII:
ID6YB4W3V8
Molecule Type:
Small molecule
Molecular Formula:
C21H20N4
Molecular Weight:
328.42
AlogP:
4.96
PSA:
52.74
HBD:
3.0
HBA:
#RotB:
6.0
Source:
L-778123
1
Small molecule
Investigational
Unknown
Unknown
Head and Neck Neoplasms; Lymphoma
Unknown
L-778123
×
Maximum Phase:
1
First Approval:
None
UNII:
31ZXM8ZKQ3
Molecule Type:
Small molecule
Molecular Formula:
C22H20ClN5O
Molecular Weight:
405.89
AlogP:
3.31
PSA:
65.16
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ABT-102
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vanilloid receptor antagonist
ABT-102
×
Maximum Phase:
1
First Approval:
None
UNII:
J0YBN3USJN
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O
Molecular Weight:
348.45
AlogP:
4.67
PSA:
69.81
HBD:
3.0
HBA:
#RotB:
2.0
Source:
NORCANTHARIDIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
NORCANTHARIDIN
×
Maximum Phase:
1
First Approval:
None
UNII:
8452E71EO7
Molecule Type:
Small molecule
Molecular Formula:
C8H8O4
Molecular Weight:
168.15
AlogP:
-0.14
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ISOAMYL 2-CYANOACRYLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ISOAMYL 2-CYANOACRYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VT-1598
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
VT-1598
×
Maximum Phase:
1
First Approval:
None
UNII:
AV9K9X720D
Molecule Type:
Small molecule
Molecular Formula:
C31H20F4N6O2
Molecular Weight:
584.53
AlogP:
4.88
PSA:
109.74
HBD:
1.0
HBA:
#RotB:
8.0
Source:
LY03005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LY03005
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUOROACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUOROACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
AP1JV9U41M
Molecule Type:
Small molecule
Molecular Formula:
C2H3FO2
Molecular Weight:
78.04
AlogP:
0.04
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
OSI-027
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Serine/threonine-protein kinase mTOR inhibitor
OSI-027
×
Maximum Phase:
1
First Approval:
None
UNII:
25MKH1SZ0M
Molecule Type:
Small molecule
Molecular Formula:
C21H22N6O3
Molecular Weight:
406.45
AlogP:
3.22
PSA:
131.42
HBD:
3.0
HBA:
#RotB:
4.0
Source:
RELACATIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RELACATIB
×
Maximum Phase:
1
First Approval:
None
UNII:
BL51M8CB8R
Molecule Type:
Small molecule
Molecular Formula:
C27H32N4O6S
Molecular Weight:
540.64
AlogP:
2.9
PSA:
138.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
SERIDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Dopamine D2 receptor modulator
SERIDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
1359K87ZYE
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
RO-4987655
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
RO-4987655
×
Maximum Phase:
1
First Approval:
None
UNII:
I3733P75ML
Molecule Type:
Small molecule
Molecular Formula:
C20H19F3IN3O5
Molecular Weight:
565.29
AlogP:
3.16
PSA:
100.13
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CEP-2563
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neurotrophic tyrosine kinase receptor inhibitor
CEP-2563
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEDALINAB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cannabinoid CB2 receptor agonist
TEDALINAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5R7X34Y6Q1
Molecule Type:
Small molecule
Molecular Formula:
C19H21F2N3O
Molecular Weight:
345.39
AlogP:
4.04
PSA:
46.92
HBD:
1.0
HBA:
#RotB:
2.0
Source:
NERINDOCIANINE
1
Small molecule
Investigational
Unknown
Unknown
Wounds and Injuries
Unknown
NERINDOCIANINE
×
Maximum Phase:
1
First Approval:
None
UNII:
1GZ5G85KVT
Molecule Type:
Small molecule
Molecular Formula:
C44H52N2O16S5
Molecular Weight:
1025.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
79
80
81
82
83
84
85
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA